| Literature DB >> 31425508 |
Inge Kroidl1,2,3, Mkunde Chachage1,2, Jonathan Mnkai2, Anthony Nsojo2, Myrna Berninghoff1, Jaco J Verweij4, Lucas Maganga2, Nyanda E Ntinginya2, Leonard Maboko2, Petra Clowes1,2, Michael Hoelscher1,2,3, Elmar Saathoff1,3, Christof Geldmacher1,3.
Abstract
BACKGROUND: Susceptibility to HIV has been linked to systemic CD4+ T cell activation in cohorts of seronegative individuals with high HIV-exposure risk. We recently described an increased risk of HIV transmission in individuals infected with Wuchereria bancrofti, the causative agent for lymphatic filariasis, in a prospective cohort study. However, the reason for this phenomenon needs further investigation. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2019 PMID: 31425508 PMCID: PMC6736309 DOI: 10.1371/journal.pntd.0007623
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1Participants and their grouping according to HIV and helminth infection status.
For the analysis only HIV negative individuals with valid data for flow cytometry and W. bancrofti were included. The participants were separated into three different sub groups-.
Participant characteristics by helminth status.
The group of W. bancrofti infected individuals was compared to helminth–free individuals and a group of participant infected with other helminth species. For each group the median age, gender distribution, pathology, the mean number of different helminth species, and the percentage of each type of helminth in the respective group, median eosinophil count and percentage of individuals with fever is given.
| Helminth negative | | Combined group of individuals infected with other helminths | |
|---|---|---|---|
| 42 | 33 | 160 | |
| 37.2 | 31.6 | 31.4 | |
| 19 (45%) | 16 (48%) | 63 (39%) | |
| 0 | 2.3 | 1.4 | |
| 4 (9.5%) | 2 (6.1%) | 14 (8.8%) |
Fig 2Eosinophil counts and polyparasitism.
Eosinophil counts were available for 37 study participants without helminth infection, 87 with one helminth species, 46 with two species, and 7 with three or more helminth species. Increasing numbers of eosinophils were seen with polyparasitism. Kruskal-Wallis testing showed significant differences between groups overall (p = 0.0001) as well as Mann-Whitney testing to compare the groups separately.
Fig 3A: Expression of HLADR on CD4 T cells in relation to the helminth infection status. The percentage of HLADR expressing CD4 T cells is shown for the three categories of participants. Kruskal-Wallis testing showed significant difference between groups overall (p = 0.0168). W. bancrofti-infected individuals had significantly more HLADR expressing CD4 T cells compared to helminth free individuals or study participants infected with other helminths as shown by Mann-Whitney test. B: Association of polyparasitism with activation status. Number of eosinophils is shown for participants with increasing numbers of helminth species. Kruskal-Wallis testing showed no significant difference between groups (p = 0.917) as well as Mann-Whitney test.
Fig 4A: Association of helminth status with the frequency of HLA-DR CD38 CD4 T cells. The percentage of HLA-DR+ CD38+ expressing CD4 T cells is shown for the three categories of participants. Kruskal-Wallis testing showed significant difference between groups overall (p = 0.044). A significant difference was seen between the subgroup of individuals without helminths and the W. bancrofti- infected participants (using Mann-Whitney testing). B: Association of polyparasitism with the frequency of HLA-DR CD38 CD4 T cells. The percentage of HLA-DR+ CD38+ expressing CD4 T cells is shown for participants with increasing numbers of helminth species. Kruskal-Wallis testing showed no significant difference between groups (p = 0.262), as did the Mann-Whitney.
Association of helminth infections with percent of HLA-DRpos CD4 T cells.
Uni- and multi-variable mixed-effects linear regression results, with random effect for residence in Kyela site, multivariable results adjusted for all variables shown.
| univariable | multivariable | |||||||
|---|---|---|---|---|---|---|---|---|
| Covariate | N | Mean | Coef. | 95% CI | p-value | Coef. | 95% CI | p-value |
| | - | - | 0,13 | (0.08 to 0.18) | 0.0000 | 0,14 | (0.09 to 0.18) | 0.0000 |
| | 131 | 8,78 | 0,00 | - | - | 0,00 | - | - |
| | 95 | 8,45 | -0,56 | (-1.71 to 0.58) | 0.3332 | 0,15 | (-0.92 to 1.21) | 0.7887 |
| | 200 | 8,50 | 0,00 | - | - | 0,00 | - | - |
| | 20 | 10,39 | 1,99 | (0.04 to 3.95) | 0.0460 | 1,36 | (-0.45 to 3.18) | 0.1412 |
| | 6 | 7,39 | -0,48 | (-3.96 to 3.00) | 0.7860 | -0,13 | (-3.35 to 3.09) | 0.9359 |
| | 193 | 8,31 | 0,00 | - | - | 0,00 | - | - |
| | 33 | 10,59 | 1,83 | (0.14 to 3.52) | 0.0337 | 1,58 | (0.08 to 3.09) | 0.0392 |
| | 147 | 8,83 | 0,00 | - | - | 0,00 | - | - |
| | 79 | 8,29 | -0,62 | (-1.79 to 0.55) | 0.3019 | -0,74 | (-1.83 to 0.35) | 0.1827 |
| | 177 | 8,25 | 0,00 | - | - | 0,00 | - | - |
| | 49 | 10,05 | 1,49 | (0.11 to 2.86) | 0.0337 | 2,12 | (0.80 to 3.43) | 0.0016 |
| | 189 | 8,34 | 0,00 | - | - | 0,00 | - | - |
| | 37 | 10,15 | 1,15 | (-0.53 to 2.83) | 0.1807 | 1,82 | (0.34 to 3.31) | 0.0162 |
| | 145 | 8,64 | 0,00 | - | - | 0,00 | - | - |
| | 81 | 8,63 | -0,09 | (-1.26 to 1.08) | 0.8839 | 1,46 | (0.28 to 2.65) | 0.0155 |
| | 209 | 8,67 | 0,00 | - | - | 0,00 | - | - |
| | 17 | 8,22 | -0,48 | (-2.60 to 1.64) | 0.6573 | 0,71 | (-1.26 to 2.67) | 0.4818 |
N = number of observations; Mean = mean outcome; Coef. = coefficient; 95% CI = 95% confidence interval
* reference stratum
Associations of filariasis infection with different markers of immune activation.
Separate uni- and multi-variable mixed-effects linear regression models for each marker with random effect for residence at Kyela site. Differences in number of observations are due to missing outcome data.
| Univariable | Multivariable | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Outcome | N | Mean | Coef. | 95% CI | p-value | Coef. | 95% CI | p-value | |
| neg. | 193 | 8,31 | 0,00 | - | - | 0,00 | - | - | |
| pos. | 33 | 10,59 | 1,83 | (0.14 to 3.52) | 0.033 | 1,58 | (0.08 to 3.09) | 0.039 | |
| neg. | 189 | 2,82 | 0,00 | - | - | 0,00 | - | - | |
| pos. | 31 | 3,69 | 0,86 | (0.21 to 1.52) | 0.009 | 0,84 | (0.19 to 1.50) | 0.011 | |
| neg. | 192 | 20,8 | 0,00 | - | - | 0,00 | - | - | |
| pos. | 33 | 29,5 | 1,69 | (-3.18 to 6.56) | 0.496 | 0,47 | (-3.96 to 4.89) | 0.836 | |
| neg. | 189 | 7,69 | 0,00 | - | - | 0,00 | - | - | |
| pos. | 32 | 13,42 | 3,49 | (0.94 to 6.04) | 0.007 | 3,45 | (0.91 to 5.98) | 0.007 | |
| neg. | 189 | 20,04 | 0,00 | - | - | 0,00 | - | - | |
| pos. | 31 | 24,10 | 4,06 | (0.99 to 7.13) | 0.009 | 3,16 | (0.17 to 6.15) | 0.038 | |
| neg. | 178 | 2,258 | 0,00 | - | - | 0,00 | - | - | |
| pos. | 30 | 2,453 | 0,13 | (-0.30 to 0.57) | 0.549 | 0,03 | (-0.40 to 0.45) | 0.898 | |
| neg. | 170 | 24,06 | 0,00 | - | - | 0,00 | - | - | |
| pos. | 30 | 25,15 | 1,09 | (-2.29 to 4.47) | 0.528 | 1,45 | (-2.03 to 4.93) | 0.414 | |
| neg. | 170 | 54,47 | 0,00 | - | - | 0,00 | - | - | |
| pos. | 30 | 55,80 | 1,34 | (-3.99 to 6.66) | 0.622 | 2,55 | (-2.89 to 8.00) | 0.358 | |
| neg. | 185 | 799 | 0,00 | - | - | 0,00 | - | - | |
| pos. | 31 | 699 | -100,43 | (-244.95 to 44.10) | 0.173 | -65,07 | (-214.22 to 84.09) | 0.392 | |
N = number of observations; Mean = mean outcome; Coef. = coefficient; 95% CI = 95% confidence interval
* unadjusted, but with random effect for Kyela site
** with random effect for Kyela site and adjusted for age, sex, current fever, and for hookworm, A. lumbricoides, T. trichiura, S. mansoni & haematobium infection. Full models showing all co-variates are contained in the supplement.
Fig 5Correlation of effector memory cells (CD27negCD45ROpos CD4 T cells) and activation status (HLADRpos CD4 T cells).
A positive correlation was found (Spearman’s rho = 0.617, p<0.001).